Gerber Kawasaki Wealth & Investment Management’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-102
Closed -$6K 467
2021
Q3
$6K Buy
+102
New +$6K ﹤0.01% 721